Literature DB >> 19191026

Muscarinic inhibition of hippocampal and striatal adenylyl cyclase is mainly due to the M(4) receptor.

Gonzalo Sánchez1, Natalia Colettis, Pablo Vázquez, Carlos Cerveñansky, Alejandra Aguirre, Jorge A Quillfeldt, Diana Jerusalinsky, Edgar Kornisiuk.   

Abstract

The five muscarinic acetylcholine receptors (M(1)-M(5)) are differentially expressed in the brain. M(2) and M(4) are coupled to inhibition of stimulated adenylyl cyclase, while M(1), M(3) and M(5) are mainly coupled to the phosphoinositide pathway. We studied the muscarinic receptor regulation of adenylyl cyclase activity in the rat hippocampus, compared to the striatum and amygdala. Basal and forskolin-stimulated adenylyl cyclase activity was higher in the striatum but the muscarinic inhibition was much lower. Highly selective muscarinic toxins MT1 and MT2-affinity order M(1) > or = M(4) >> others-and MT3-highly selective M(4) antagonist-did not show significant effects on basal or forskolin-stimulated cyclic AMP production but, like scopolamine, counteracted oxotremorine inhibition. Since MTs have negligible affinity for M(2), M(4) would be the main subtype responsible for muscarinic inhibition of forskolin-stimulated enzyme. Dopamine stimulated a small fraction of the enzyme (3.1% in striatum, 1.3% in the hippocampus). Since MT3 fully blocked muscarinic inhibition of dopamine-stimulated enzyme, M(4) receptor would be responsible for this regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19191026     DOI: 10.1007/s11064-009-9916-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  38 in total

1.  Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.

Authors:  A I Levey; C A Kitt; W F Simonds; D L Price; M R Brann
Journal:  J Neurosci       Date:  1991-10       Impact factor: 6.167

2.  Identification of rat brain muscarinic M4 receptors coupled to cyclic AMP using the selective antagonist muscarinic toxin 3.

Authors:  M C Olianas; A Adem; E Karlsson; P Onali
Journal:  Eur J Pharmacol       Date:  1998-09-18       Impact factor: 4.432

Review 3.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

4.  Anti-muscarinic toxins from Dendroaspis angusticeps.

Authors:  J S Liang; J Carsi-Gabrenas; J L Krajewski; J M McCafferty; S L Purkerson; M P Santiago; W L Strauss; H H Valentine; L T Potter
Journal:  Toxicon       Date:  1996 Nov-Dec       Impact factor: 3.033

5.  Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes.

Authors:  E G Peralta; A Ashkenazi; J W Winslow; J Ramachandran; D J Capon
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

6.  Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation.

Authors:  A I Levey; S M Edmunds; V Koliatsos; R G Wiley; C J Heilman
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

Review 7.  Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory.

Authors:  E A van der Zee; P G Luiten
Journal:  Prog Neurobiol       Date:  1999-08       Impact factor: 11.685

8.  Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions.

Authors:  D Jerusalinsky; E Kornisiuk; R Bernabeu; I Izquierdo; C Cerveñansky
Journal:  Toxicon       Date:  1995-04       Impact factor: 3.033

9.  Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors.

Authors:  Alan L Harvey; Edgar Kornisiuk; Karen N Bradley; Carlos Cerveñansky; Rosario Durán; Martin Adrover; Gonzalo Sánchez; Diana Jerusalinsky
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

10.  Muscarinic toxin selective for m4 receptors impairs memory in the rat.

Authors:  D Jerusalinsky; E Kornisiuk; P Alfaro; J Quillfeldt; M Alonso; E R Verde; C Cerveñansky; A Harvey
Journal:  Neuroreport       Date:  1998-05-11       Impact factor: 1.837

View more
  6 in total

1.  Functional characterization of AC5 gain-of-function variants: Impact on the molecular basis of ADCY5-related dyskinesia.

Authors:  T B Doyle; M P Hayes; D H Chen; W H Raskind; V J Watts
Journal:  Biochem Pharmacol       Date:  2019-02-14       Impact factor: 5.858

2.  M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.

Authors:  Weixing Shen; Joshua L Plotkin; Veronica Francardo; Wai Kin D Ko; Zhong Xie; Qin Li; Tim Fieblinger; Jürgen Wess; Richard R Neubig; Craig W Lindsley; P Jeffrey Conn; Paul Greengard; Erwan Bezard; M Angela Cenci; D James Surmeier
Journal:  Neuron       Date:  2015-11-18       Impact factor: 17.173

Review 3.  Striatal cholinergic interneurons and Parkinson's disease.

Authors:  Asami Tanimura; Tristano Pancani; Sean Austin O Lim; Cecilia Tubert; Alexandra E Melendez; Weixing Shen; Dalton James Surmeier
Journal:  Eur J Neurosci       Date:  2017-07-20       Impact factor: 3.386

4.  Control of striatal signaling by g protein regulators.

Authors:  Keqiang Xie; Kirill A Martemyanov
Journal:  Front Neuroanat       Date:  2011-08-08       Impact factor: 3.856

Review 5.  Striatal synaptic adaptations in Parkinson's disease.

Authors:  Weixing Shen; Shenyu Zhai; D James Surmeier
Journal:  Neurobiol Dis       Date:  2022-03-08       Impact factor: 7.046

Review 6.  Structural and Functional Diversity of Animal Toxins Interacting With GPCRs.

Authors:  Anne-Cécile Van Baelen; Philippe Robin; Pascal Kessler; Arhamatoulaye Maïga; Nicolas Gilles; Denis Servent
Journal:  Front Mol Biosci       Date:  2022-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.